findmyKOL
Clinical trialNCT06491732RecruitingObservational

EIM Via the Myolex mScan as an ALS Biomarker

SponsorBeth Israel Deaconess Medical CenterEnrollment80Amyotrophic Lateral Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

    Jourdan MilliardShafeeq Ladha, MD
    Recruiting
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

    Masumeh Hatami, MDSeward Rutkove, MD
    Recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Sabrina Paganoni, MD
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Stephen Goutman, MD
    Recruiting
  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, United States

    Elijah Stommel, MD, PhDMark Garret, MD
    Recruiting
  • Atrium Health Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina, United States

    Jim Caress, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2025
Primary completion
30 May 2027
Completion
30 May 2027
Last update posted
22 Apr 2026
Registered enrollment
80
Registry id
NCT06491732

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.